Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials.
Taro KishiKenji SakumaMakoto OkuyaYuki MatsudaSatoru EsumiYasuhiko HashimotoMasakazu HatanoNobumi MiyakeItaru MiuraKazuo MishimaNakao IwataPublished in: Bipolar disorders (2021)
SGA+MS prevented recurrence for up to 12 months for BDI compared with placebo+MS.